Skip to main content
https://pbs.twimg.com/media/F8aXc1AXIAASObD.jpg
SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica NEJM reported today that #PMR patients who fail to respond to standard doses of prednisone therapy, were significantly better when given the IL-6 inhibitor sarilumab (than placebo). https://t.co/k5SAshxdsg https://t.co/tMtRHn2C6j
Dr. John Cush
14-10-2023
×